Effect of Continuous 0.5% Ganciclovir Eye Drop Treatment in Secondary Glaucoma Associated with Cytomegalovirus Anterior Uveitis
Takaaki Otsuka, Katsuhiko Yokoyama, Takako Nakamuro, Yuji Sakino, Satoko Nakano, Kenichi Kimoto & Toshiaki Kubota · Ophthalmology Research: An International Journal · 2021
Purpose: The purpose of this study was to investigate the treatment outcomes of secondary glaucoma caused by cytomegalovirus (CMV)-anterior uveitis (AU) with continuous 0.5% ganciclovir eye drop. Study Design: Retrospective observational study. Place and Duration of Study: Depart...
Open access
Research Article
10.9734/or/2021/v14i130179